DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: It is difficult to explain this phenomenon, but it is possible that a supplementary mechanism is responsible for the dystrophin defect, which should be investigated further and may be a novel target for treating patients with dystrophinopathies.